Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI

ClinicalTrials.gov ID: NCT04717492

Public ClinicalTrials.gov record NCT04717492. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 5:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Observational Study of Beta-Blocker Use in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Acute Myocardial Infarction

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is a prospective, observational study of patients admitted to the BLOCK COPD network hospitals with acute AMI and Chronic Obstructive Pulmonary Disease (COPD) to determine the prevalence of COPD in patients admitted to the hospital with an acute myocardial infarction (AMI) and to characterize the phenotypic expression and severity of their underlying lung disease. Patients with will be identified via the EMR. 571 participants will be enrolled.

Study identification

NCT ID
NCT04717492
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
University of Minnesota
Other
Enrollment
584 participants

Conditions and interventions

Eligibility (public fields only)

Age range
35 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 28, 2020 (Actual)
Primary completion
May 18, 2022 (Actual)
Completion
Dec 2, 2022 (Actual)
Last update posted
Jan 31, 2025

2020 – 2022

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
University of California, San Francisco-Fresno Fresno California 93701 —
LA BioMed at Harbor-UCLA Medical Center Los Angeles California 90502 —
University of California at San Francisco San Francisco California 94143 —
National Jewish Medical & Research Center Denver Colorado 80206 —
North Florida/South Georgia Veterans Health System Gainesville Florida 32608 —
Northwestern University Chicago Illinois 60611 —
Louisiana State University New Orleans Louisiana 70112 —
University of Maryland Baltimore Baltimore Maryland 21201 —
University of Michigan Ann Arbor Michigan 48109 —
Veteran's Administration Medical Center Minneapolis Minnesota 55417 —
HealthPartners Research Foundation Minneapolis Minnesota 55440 —
Mayo Clinic Rochester Minnesota 55905 —
NewYork-Presbyterian Brooklyn Methodist Hospital Brooklyn New York 11215 —
New York Presbyterian/Queens Flushing New York 11355 —
Columbia University New York New York 10027 —
Weill Cornell Medicine New York New York 10065 —
Cincinnati VA Medical Center Cincinnati Ohio 45220 —
Cleveland Clinic Cleveland Ohio 44195 —
Temple University Lung Center Philadelphia Pennsylvania 19140 —
University of Pittsburgh Pittsburgh Pennsylvania 15213 —
University of Utah Health Sciences Center Salt Lake City Utah 84132-4701 —
The University of Vermont Burlington Vermont 05405 —
University of Washington School of Medicine Spokane Washington 99258 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04717492, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 31, 2025 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04717492 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →